This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Lilly announces Guidant IPO for 20% of new company's stock
13 Jul 1999
Eli Lilly's device spin-off, Guidant Corp. (cardiac rhythm management, coronary artery disease intervention, minimally invasive surgery) has completed its IPO of 14.26 million shares at $14.50 per share, netting $192.5 million.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?